Pfizer and BioNTech to provide an additional 100 million COVID-19 vaccines (COMIRNATY) to the EU

Pfizer and BioNTech announced today that they will provide an additional 100 million COMIRNATY units to 27 EU member states by 2021.
the EU has now purchased a total of 300 million COMIRNATY units.
Pfizer Chairman and CEO Albert Bourla said, "As the deadly virus continues to spread at an alarming rate, we remain committed to bringing this vaccine to more Europeans as soon as possible."
with the European Commission, EU member states and healthcare providers, we will be able to reach 150 million people across Europe."
Uur Sahin, CEO and co-founder of BioNTech, said: "An additional 100 million doses of the vaccine will be delivered in 2021 to support the vaccination campaign that began two days ago in all 27 member states.
our goal remains to provide safe and effective COVID-19 vaccines to as many people as possible around the world."
COMIRNATY will be produced at BioNTech and Pfizer's European production sites.
have previously said they have the potential to supply up to 1.3 billion doses of COMIRNATY worldwide by the end of 2021, depending on production capacity.
。